-
PathAI will share five new posters at SITC 2022, all developed in collaboration with biopharmaceutical partners, that highlight their new AI-model development to support advances in oncology research across several disease areas such as non-small cell lung cancer (NSCLC), cholangiocarcinoma, and urothelial carcinoma.
Nov 6, 2022
-
A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.
Nov 6, 2022
-
The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.
Nov 6, 2022
-
Nov 2, 2022
-
Nov 3, 2022
-
Nov 2, 2022
-
Oct 31, 2022
-
Nov 1, 2022
-
BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.
Nov 1, 2022
-
BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.
Nov 1, 2022
-
BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.
Nov 1, 2022
-
Oct 31, 2022
-
Oct 31, 2022
-
Oct 31, 2022
-
EKF to showcase powerful digital connectivity products and contract manufacturing capabilities at Medica 2022 in Hall 3 at Stand B69
Oct 31, 2022
-
Findings illustrate promise of technology to lower misdiagnosis rate for deadliest form of skin cancer
Oct 31, 2022
-
Oct 31, 2022
-
Oct 31, 2022
-
Oct 31, 2022
-
Oct 31, 2022